|
Dr. Mark R. Hurtt was named Alseres' Chief Medical Officer in October 2005. Most recently, Dr. Hurtt was Senior Director of Clinical Research at Neurogen Corporation in Branford, CT.. Prior to Neurogen, Dr. Hurtt was Director of Drug Development and Director of Clinical Research at Pfizer Global Research and Development in Ann Arbor, MI. During his career, Dr. Hurtt has overseen CNS development programs in Parkinson's Disease, Alzheimer's disease, schizophrenia, pain, anxiety, and depression. Dr. Hurtt is Board certified in Neurology and Neuropathology. He received his medical degree from Jefferson Medical College and served as a Medical Officer in the United States Navy. He trained in neurology and neuropathology and was an assistant professor in the Departments of Neurology and Pathology at the University of Pittsburgh. | 